Clinical Trial Update: Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating anti-androgens and cabazitaxel in defining complete response after prostatectomy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• anti-androgens

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED